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Abstract A novel two-step sequential extraction has been
developed to assess the bioaccessibility of As, Cd, Cr, Cu,
Fe, Mn, Ni, Pb and Zn in airborne particulate matter following
inhalation and transport into the human gastrointestinal tract
by mucociliary clearance. A new artificial mucus fluid (AMF)
was used to determine the bioaccessible potentially toxic ele-
ment (PTE) fraction in the upper airways, in sequence with the
simplified bioaccessibility extraction test (SBET) or the stom-
ach phase of the unified bioaccessibility method (gastric fluid
only) (UBMG). Filter dynamic measurement system TX40
filters smeared with soil reference material (BGS RM 102)
were used as test samples. Analysis was performed by ICP-
MS. Comparison between results obtained for soil alone and
when the soil was supported on TX40 filters indicated that the
presence of the substrate did not affect the extraction efficien-
cy, although a large Zn blank was detected. The sequential
AMF→SBET extraction liberated similar amounts of Fe,
Mn, Ni and Zn to the SBET alone; but significantly less Cd;
and significantly more As, Cr, Cu and Pb. The sequential
AMF→UBMG extraction liberated similar amounts of Cd,
Cr, Mn and Zn to the UBMG alone, but significantly less
As, Fe and Ni; and significantly more Cu and Pb. Enhanced
extractability was due to the greater quantities of exchange-
able ions and complexing agents present. Adoption of a two-
step sequential extraction (AMF followed by either the SBET
or the UBMG) is recommended because it is more represen-
tative of biological conditions and avoids overestimation or
underestimation of bioaccessible PTE concentrations.
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Introduction
Potentially toxic elements (PTE) associated with inhalable
airborne particulate matter (PM10) can cause adverse effects
on human health, such as increased prevalence of heart dis-
ease and lung cancer, especially in urban and (current and
former) industrial areas [1, 2]. The severity of health effects
depends on the availability of the PTE for absorption into
the body, and this has led to growing interest in the devel-
opment of analytical protocols to estimate the bioaccessibi-
lity of PTE bound to PM10 following inhalation of contam-
inated particles [3].
The human respiratory system consists of two functional
regions: the conducting airways (i.e. the nose, pharynx, lar-
ynx, trachea, bronchi and bronchioles) and the respiratory
region (i.e. the lungs) [1, 4, 5]. Airways surface liquid (ASL)
lines the conducting regions [2, 6]. This consists of three
layers: a basal sol layer, a thin layer of surfactant, and a mucus
layer. The viscosity and elasticity of the mucus layer are
higher than the sol layer, and so the mucus can be cleared
out of the deeper airways and nasal cavity, and transported
into the gastrointestinal tract by movement of cilia [1, 7].
Inhaled PM is initially trapped by the mucus layer [1, 7].
Thereafter, particles <2.5 μm in diameter penetrate to the
lungs [2], whilst particles with diameter in the range 2.5–
10 μm (which can constitute up to 95% of those inhaled [8])
are transported from the conducting airways to the gastroin-
testinal tract by mucociliary clearance [2, 9, 10]. Leaching can
occur during transport and substances released can be
absorbed by cells lining the conducting airways [2, 9,
11–13]. Thus, although the mucus layer is sometimes
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considered one of the barriers to absorption of inhaled sub-
stances in the respiratory system, it can also serve as a trans-
port pathway by which PTE associated with PM can enter the
body, with factors such as molecular weight, solubility and
electrical charge determining the absorption kinetics for spe-
cific species [2]. As PTE can dissolve and be absorbed both en
route to, and within, the stomach, analytical methods used to
assess the bioaccessibility of PTE associated with inhaled PM
should ideally include two sequential compartments: the first
representing the conducting airways and the second
representing the gastrointestinal tract. To date, however, only
single step extractions have been applied in this field.
The original [14] and modified [3, 15–20] versions of
Gamble’s solution have been used in studies to estimate
the inhaled bioaccessible fraction of PTE in PM10 derived
from a variety of sources, including coal-derived fly ash
[21], mine waste [18, 22], urban surface soils [39] and
smelters dust. [23] In addition, PM10 collected on different
types of filters (quartz fibre filters [24, 25], Teflon filters
[26] and cellulose nitrate filters [27]) have been analysed.
A key study [3] proposed a novel in vitro simulated epithe-
lial lung fluid that contained high molecular mass proteins,
antioxidants and a surfactant, in addition to inorganic com-
ponents, and so more closely simulated conditions in the
real human respiratory system. This was successfully ap-
plied to assess the bioaccessibility of Pb following inhala-
tion of PM10 from urban surface soils, tailings and smelter
wastes from Mitrovica, Kosovo. The work clearly demon-
strated the importance of the direct inhalation pathway in
adding significantly to Pb intake for a population chronical-
ly exposed to contaminated dust. However, the fluid used
represented the sum of the two layers of ASL, whereas PM10
are generally in contact only with mucus. Developments of
a specifically mucus-like extractant—an artificial mucus
fluid (AMF)—would therefore be desirable.
For the second compartment, any established oral bioac-
cessibility extraction test could in principle be used. Both the
simplified bioaccessibility extraction test (SBET) [28] and the
unified bioaccessibility method (UBM) [29] have been
employed for determining the bioaccessible fraction of PTE
in PM [30–34]. In some cases, the PM10 was obtained from
urban soil samples [30, 31] or from urban street dust [32]
whilst, in others, filter-based samples were used [33, 34]. A
recent study [34] miniaturised the SBET and the stomach
phase of the UBM, and successfully applied the methods de-
veloped to measure the bioaccessible fraction of PTE in PM10
supported on TX40 filters employed in the filter dynamics
measurement system (FDMS) samplers widely used for con-
tinuous monitoring of ambient particulate matter.
The aim of the current study was to establish a two-step
sequential extraction method for determining the bioaccessi-
ble fraction of PTE in PM10 transported to the gastrointestinal
tract by mucociliary clearance that more accurately simulates
biological conditions. The procedure developed incorporated
the following:
– A novel AMF to assess bioaccessibility during transport,
followed by
– A modified SBET or a stomach phase UBM test [34] to
assess bioaccessibility on arrival in the stomach.
As in previous work [34], the study was carried out using
surrogate PM10 samples prepared from a soil reference mate-
rial—BGS RM 102 Ironstone Soil (with target values for
amounts of As, Cd and Pb extractable by the UBM)—since
this allowed replicate test samples to be prepared for use in
method comparison and to assess the repeatability of the new
extraction. The surrogate samples were prepared on TX40
filters so that any issues arising from extracting particles sup-
ported on filters could be detected and overcome (e.g. the
presence of filter blanks) with the goal of developing an ana-
lytical method that would be directly applicable to genuine
PM samples collected as part of routine air quality monitoring
campaigns worldwide.
Experimental
Selection of constituents for AMF and AMF extraction
parameters
Table 1 shows the composition of the AMF used in step 1 of
the sequential extraction of simulated PM10 samples.Mucus is
a heterogeneous mixture of proteins, lipids and salts [9, 11,
35]. After water, which constitutes 95–97% [7] of mucus, the
second most abundant components by mass are proteins.
These include mucins—glycoproteins responsible for the vis-
coelastic properties of mucus [35]—and serum proteins such
as albumin [7, 9, 11, 35]. Mucus is typically composed of 0.5–
1% free protein and 0.5–2% mucin [1, 4, 11]. Due to low
solubility in water, and to minimise the total dissolved solids
content in extracts, a mucin concentration of 0.5% (i.e.
5 g L−1) was selected. The concentration of albumin in ASL
is 480–730 mg L−1 [4] and the middle of this range
(610 mg L−1) was used. Inorganic salts constitute ∼1% by
weight of mucus [1, 7, 11, 27]; the concentrations of Na+,
Cl− and K+ in ASL have been reported as 1838–1953,
2658–2836 and 586 mg L−1, respectively [4], or approximate-
ly 45% less than plasma for Na+ and Cl− and 600%more than
plasma for K+ [11]. The concentrations of KCl, NaCl and
NaHCO3 in AMF were chosen based on the above values,
whilst other salts, i.e. NaH2PO4, Na2SO4, CaCl2·2H2O and
MgCl2·6H2O, were incorporated at levels similar to their con-
centrations in the original Gamble solution [14]. Lipids are
another of the principle components of mucus [7, 9, 11, 35];
it is composed of 1% lipids [1] that reduce the surface tension
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between the layers of ASL [1, 9]. The majority of mucus lipids
are phospholipids, and the most abundant is phosphatidylcho-
line [4], which constitutes 11% of total lipids (i.e. 0.11% of
mucus by mass) [36]. Therefore, 1.10 g L−1 of dipalmitoyl
phosphatidylcholine (DPPC) was included in the AMF.
Besides mucins, secretory cells release a variety of antimicro-
bial molecules, e.g. lysozyme [7, 11], that destroys bacteria in
respiratory mucus [35]. The concentration of lysozyme in
ASL is 0.1–1 mg mL−1 [4] and the middle of this range
(0.5 mg mL−1) was chosen. Glutathione is also present in
ASL at 132 mg L−1 [4] and so this concentration was adopted.
According to Sexton et al. [37], a moderate seasonal inha-
lation dose for PM10 is 100 mg and so this sample mass was
selected. Human studies using the tablet inhalation technique
[38] demonstrated that all deposited particles >6 μm in diam-
eter were removed from the airways by mucociliary clearance
within 24 h and that 49 ± 9% of particles had a mean half time
of 3.0 ± 1.6 h in healthy circumstances. Given that the average
lengths of the human pharynx, larynx, trachea, right and left
bronchus are 13, 10.4, 12, 2.5 and 5 cm, respectively [39], and
that minimum and maximum velocities of mucociliary clear-
ance are 0.4 and 2 cm min−1 [1, 4, 11], an extraction time of
1 h was selected. The maximum volume of ASL produced
daily ranges from 100 mL [4] to >125 mL [40]. Estimates of
the relative proportions that are absorbed and transported to
the gastrointestinal tract differ: Schans [12] reported that
20 mL of mucus per day reached the trachea, whilst King
[9] found that 10 mL per day reached the larynx, and Fahy
[7] claimed 30 mL per day was deposited in the gastrointesti-
nal tract. In the current study, 120 mL was chosen for the
volume of mucus produced per day and 30 mL per day for
the volume transported to the stomach by mucociliary clear-
ance. Hence, the AMF extraction was performed for 1 h using
5 mL of reagent, 1.5 mL of which was carried forward into
step 2—the gastrointestinal step—of the sequential extraction.
Overall, ASL is very slightly acidic (mean pH 6.78 [4, 6]), but
the pH of mucus is around 7 [41] and so the latter value was
selected for the AMF extraction. As the extraction was
intended to simulate physiological conditions, it was carried
out at the basal human body temperature. The final protocol
thus involved extraction of 100 mg samples for 1 h in 5 mL of
AMF adjusted to a pH of 7.00 ± 0.20 at 37 ± 2 °C (for further
details, see BPreparation of AMF^ and BSequential bioacces-
sibility extraction procedure^ sections).
Apparatus and reagents
Blank Pallflex TX40 FDMS filters were supplied by Air
Monitors (Gloucestershire, UK). These are made of borosili-
cate microfibres reinforced with woven glass cloth and bond-
ed with polytetrafluoroethylene (5 mg cm−2, 47 mm diame-
ter). The pH of solutions was measured by using a Mettler-
Teledo (SevenGo™) pH meter. Suspensions were shaken in
an end-over-end rotator inside an incubator (Stuart® SI500
shaking incubator from Barloworld Scientific Ltd.,
Staffordshire, UK). All glassware and plastic ware were
soaked overnight in 10% HNO3 then rinsed three times with
deionised water before use. All chemicals were of analytical
grade. Bovine serum albumin, NaH2PO4, KCl, pancreatin
(porcine), urea, CaCl2·2H2O and pepsin (porcine) were pur-
chased form Merck (Poole, UK). Glucose, NaCl, Na2SO4,
NH4Cl, NaHCO3 and NaOH were supplied by VWR
International (Lutterworth, UK). Lysozyme, glutathione,
MgCl2·6H2O, glucuronic acid, glucosamine hydrochloride,
mucin (porcine), DPPC, hydrochloric acid (HCl) (36.5–
38%) and nitric acid (HNO3) (≥69% Trace SELECT® for
trace analysis) were obtained from Sigma Aldrich
(Gillingham, Dorset, UK). Glycine was purchased from
Fisher Scientific (Loughborough, UK). Multi-element stan-
dard stock solution (10 mg L−1 of As, Cd, Cr, Cu, Mn, Ni,
Pb and Zn) and Fe standard stock solution (1003mgL−1) were
obtained from Qmx Laboratories (Essex, UK).
Simulation of PM10 samples
Samples of PM10 were simulated by smearing blank TX40
filters with 100 mg of a soil reference material (BGS RM 102
Ironstone Soil produced by British Geological Survey,
Keyworth, UK) using a plastic spatula. This material was se-
lected due to its small particle size (50% of the material by
volume is made up of particles <7.6 μm in diameter [34]) and
because soil-derivedmaterial typically constitutes a major com-
ponent of airborne PM10. Real PM10 samples were not used
Table 1 The composition of artificial mucus fluid (AMF)
Reagent Weight of reagent (mg)
made up to 100 mL
with deionised water
Inorganic reagent
KCl 224
NaH2PO4 24
Na2SO4 14
NaCl 620
CaCl2·2H2O 74
NaHCO3 504
MgCl2·6H2O 42
Organic reagent
Glutathione 26.4
Additional reagents
Mucin 1000
Albumin 122
DPPC 220
Lysozyme 100
DPPC dipalmitoyl phosphatidylcholine
Trace element bioaccessibility in inhaled particulate matter transported to the GI tract
because their mass and composition is variable, whereas it was
important to have series of replicate samples (filters loadedwith
the same mass of a known material) for use in method devel-
opment. To investigate whether the filters affected the extrac-
tion procedure, 100mg samples of BGSRM102 Ironstone Soil
alone and blank TX40 filters were also extracted.
Preparation of AMF
To prepare 200 mL of AMF, the inorganic and organic re-
agents listed in Table 1 were dissolved in 100 mL deionised
water in separate 100 mL volumetric flasks. The prepared
reagents were then added to a 500-mL HDPE bottle contain-
ing the additional reagents. To obtain the desired pH of 7.00 ±
0.20, 200 μL of 37% HCl was added. The bottle was placed
on a magnetic stirrer for 3 h before the pHwas adjusted to 7.0
± 0.2 by using 37% HCl or 1 M NaOH.
Sequential bioaccessibility extraction procedure
Six simulated PM10 samples, six BGS RM 102 Ironstone Soil
samples, and six blank TX40 filters were placed in 150 mL
wide mouth bottles for extraction. In step 1 of the procedure,
a 5-mL aliquot of AMF adjusted to pH 7.00 ± 0.20 at 37 ± 2 °C
was added to each bottle and briefly shaken manually. The pH
of each suspension was checked and where necessary adjusted
to the desired value (7.00 ± 0.20) by using solutions of HCl (25,
50, and 100% v/v) and 1MNaOH. The bottles were shaken for
1 h at 100 rpm using an end-over-end rotator inside a pre-
heated incubator at 37 ± 2 °C. Suspensions were then decanted
into 15 mL centrifuge tubes (filters, where present, remained in
the extraction vessels) and centrifuged at 4500×g for 10 min. A
3.5-mL aliquot of the clear supernatant was removed by means
of a pipette, leaving 1.5 mL of AMF, together with the residual
soil, in the centrifuge tube. Of the 3.5 mL of extract removed,
2.5 mL was taken and diluted to 10 mL with 2% HNO3 in a
volumetric flask, then stored at 4 °C for analysis by ICP-MS
(see BChemical analyses^ section).
In step 2 of the procedure, either the SBET or the stom-
ach phase of the UBM (as modified in [34]) was applied to
the residual soil and AMF. To maintain similar solid/liquid
ratios as used in the original protocols (1 g/100 mL for the
SBET and 0.6 g/22.5 mL for the stomach phase of the
UBM), 10 mL of 0.4 M glycine was added to half of the
centrifuge tubes and 2.25 mL of UBM gastric fluid reagent
(without addition of saliva fluid since inhalable PM10 enter
the respiratory tract through the nose) to the other half of the
centrifuge tubes. Each centrifuge tube was shaken well and
then the contents decanted back into their original 150 mL
wide mouth bottle for completion of the sequential extrac-
tion procedure.
Chemical analyses
Extracts obtained were analysed by ICP-MS (Model 7700x,
Agilent Technologies, Cheshire, UK). The instrument operat-
ing conditions are shown in Table 2. The ICP-MS was cali-
brated using matrix-matched standard solutions. One of these
calibration standards was re-analysed every 10 analyses and
also at the end of the sample run to check for instrumental
drift. The recovery of the re-analysed standard was in all cases
100 ± 10% of the initial value.
Quality control
Samples were analysed in triplicate (except for AMF where
six replicates were used). To check for accuracy, the appropri-
ate extraction reagents were spiked to produce 250 μg L−1
concentrations of all PTE tested, except for Fe, where the
concentration was 10020 μg L−1 and taken through the com-
plete extraction procedure. The percentage spike recovery was
calculated by using Eq. 1.
% spike recovery ¼
measured conc:of PTEinspikedreagent−measuredconc: of PTEinunspiked reagentj j
knownconc:of PTEinspikedreagent
 
 100 ð1Þ
Results and discussion
PTE in blank TX40 FDMS filters
Previous work [34] showed that blank TX40 filters
contained significant quantities of Zn, and trace amounts
of other analytes, which could be extracted using the
SBETor the UBMG (i.e. UBM stomach phase, gastric fluid
only) procedures. This was also the case when the AMFwas
applied, either alone or sequentially with either of the oral
bioaccessibility tests (Table 3). A zinc-containing com-
pound is used as a binder in the production of the filters
[34] which are standard components of FDMS air monitors.
Elimination of the blank either through use of an alternative
filter or by washing was not considered appropriate since
the goal of the current study was to develop a method ap-
plicable to samples obtained as part of conventional air
quality monitoring campaigns, where TX40 filters are used
as the industry-standard. Instead, all results were corrected
for filter blanks for all PTE tested.
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Sequential extraction
Step 1: artificial mucus fluid
When simulated PM10 samples and samples of soil alone were
extracted using the AMF, the bioaccessible PTE concentra-
tions obtained were low, as would be expected due to the
neutral pH of the extractant. Only As, Cu, Mn and Ni were
detectable (Table 4) with the concentrations of other PTEs less
than their respective limits of detection.
Statistical results obtained (t test at 0.05 significance level)
and the calculation of the RPD showed that there was no
significant difference between the bioaccessible concentration
of PTE in soils alone and in soil on TX40 filters, except for
Mn, where larger amounts were recovered from the samples
on filters. A combination of small-scale sample heterogeneity
and use of a low sample mass (100 mg) may have enhanced
variability for this analyte.
Step 2: artificial stomach fluid
Higher analyte concentrations were obtained when the
UBMG procedure was used as the second step in the sequen-
tial extraction than when the SBET was used, except for Fe
(Table 5). Since the first step of the sequential extraction is
identical, this is probably due to the different pH values used
in the SBET (pH 1.5) and UBMG (pH 1.2). For Fe, the lower
extractability using the UBMG may be due to increased for-
mation of insoluble precipitates [42] caused by the larger
phosphate concentration present. Both of the step 2 extracts
contained phosphate derived from the 1.5 mL of AMF carried
forward from step 1 of the sequential extraction, but the
AMF→UBMG sequence involved addition of 2.25 mL of
the UBMG reagent (increasing the phosphate concentration
to 208 mg/L) whereas the SBET reagent used in the AMF→
SBET sequence contained no additional phosphate.
The RPD between the bioaccessible concentrations of PTE
obtained in soils alone and in soils on TX40 filters were <10%
for the majority of analytes confirming that the presence of the
filter did not affect the extraction efficiency, so long as blank
correction was performed. The exception was Zn, where
higher results were obtained for soil alone than for soil on
TX40 filters. It is possible that variability between the Zn
content in filters may have led to overcorrection of the filter
blank. This highlights the difficulties of determining bioacces-
sible Zn accurately when the industry-standard TX40 filter is
used.
Comparison between sequential and single extraction
Comparing the total amounts of PTE extracted from simulated
PM10 samples by the two-step sequential procedures devel-
oped—either AMF followed by SBET (AMF→SBET) or
AMF followed by UBMG (AMF→UBMG)—and the
amounts of PTE extracted when the corresponding oral bio-
accessibility tests (SBET or UBM stomach phase) were ap-
plied alone [34] revealed some interesting trends (Fig. 1).
Whilst the amounts of analyte released by single and sequen-
tial extraction were in many cases similar (i.e. relative recov-
ery values were close to 100%), the sequential AMF→SBET
method released substantially more As, Cr, Cu and Pb than the
SBET alone, whilst the sequential AMF→UBMG released
more Cu and Pb than the UBMG alone. Without the addition
of the mucus phase to create a more physiologically relevant
extraction environment, the bioaccessible concentrations of
these elements would therefore have been underestimated.
Statistical analysis (t test at 0.05 significance level) (see
Table 6) indicated that bioaccessible PTE concentrations were
significantly different between the single and sequential ex-
traction procedures for As, Cd, Cr, Cu and Pb using the SBET-
based procedures, and for As, Cu, Fe, Ni and Pb using the
UBM-based procedures. Analytes could be grouped into three
Table 2 Operating conditions of
the ICP-MS Power (W) 1550
Quadrupole bias (V) −15
Octopole bias (V) −18
Nebulizer gas flow (L min−1) 0.85
Plasma gas flow (L min−1) 15
Auxiliary gas flow (L min−1) 0.9
Isotopes determined 75As, 111Cd, 114Cd, 52Cr, 53Cr, 63Cu, 65Cu, 56Fe, 57Fe, 55Mn, 60Ni, 61Ni,
206Pb, 207Pb, 208Pb, 64Zn and 66Zn
Isotopes quantified (with internal
standards in parenthesis)
75As (72Ge), 111Cd (115In), 52Cr (45Sc), 63Cu (45Sc), 56Fe (45Sc), 55Mn
(45Sc), 60Ni (45Sc), 208Pb (209Bi) and 66Zn (72Ge)
Collision cell gas (L min−1) He (4.5) for all masses determined, except for 111Cd, 114Cd, 206Pb,
207Pb and 208Pb, where no gas mode was chosen
Sample uptake rate (mL min−1) 1
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categories for each method. The first group showed no signif-
icant difference between single and sequential extraction; the
second gave higher bioaccessible analytes concentrations
using the sequential extraction, whilst the third gave higher
bioaccessible analyte concentration using the oral bioaccessi-
bility test alone. For the SBET, the first group comprised Fe,
Mn, Ni and Zn; the second As (+127%), Cr (+31%), Cu
(+25%) and Pb (+33%); and only Cd (−23%) was present in
Table 4 Sequential extraction
step 1: bioaccessible
concentrations of potentially toxic
elements in simulated PM10
samples (soil on TX40 FDMS
filters) and in soil alone extracted
with artificial mucus fluid (n = 6)
As (mg kg−1) Cu (mg kg−1) Mn (mg kg−1) Ni (mg kg−1)
Soil S1 0.742 1.87 6.41 <0.014
S2 0.805 2.17 6.21 <0.014
S3 0.792 1.85 6.92 0.178
S4 0.821 2.00 7.95 0.230
S5 0.791 1.90 7.27 0.210
S6 0.761 1.84 8.18 0.211
Mean 0.785 1.94 7.16 0.207
SD 0.029 0.13 0.80 0.022
%RSD 3.68 6.58 11.2 10.6
Soil on TX40 filters SF1 0.818 1.99 7.52 0.210
SF2 0.859 2.03 9.96 0.205
SF3 0.821 1.83 9.81 0.187
SF4 0.839 1.91 10.6 0.232
SF5 0.836 1.92 10.9 0.273
SF6 0.798 1.72 9.78 0.432
Mean 0.828 1.90 9.76 0.222
SD 0.021 0.11 1.19 0.033
%RSD 2.52 5.84 12.2 14.9
%RPD 5.00 2.00 31.0 7.00
Spike recovery 92.3 90.4 92.6 97.1
SD standard deviation, n number of replicates, RSD relative standard deviation, < indicates a value less than the
procedural limit of detection in AMF,RPD relative percent difference = {|a1 − a2|/((a1 + a2)/2)} × 100 where a1 is
values in soil alone and a2 is values in soil loaded on TX40 filter. The concentrations of the other analytes fell
below their respective limits of detection: Cd 0.018; Cr 0.023; Fe 0.870; Pb 0.018; Zn 0.042 (all mg kg−1 ) and so
no data are reported
Table 3 Bioaccessible concentration of potentially toxic elements in
blank TX40 filters using artificial mucus fluid (AMF) alone and AMF
sequentially with the simplified bioaccessibility extraction test
(AMF→SBET) or the stomach phase (gastric fluid only) of the unified
bioaccessibility method (AMF→UBMG)
AMF alone (n = 6) AMF→SBET (n = 3) AMF→UBMG (n = 3)
μg L−1 mean ± SD
(RSD)
μg per filter mean ± SD
(RSD)
μg L−1 mean ± SD
(RSD)
μg per filter mean ± SD
(RSD)
μg L−1 mean ± SD
(RSD)
μg per filter mean ± SD
(RSD)
As <0.328 <0.002 <0.017 <0.0002 0.705 ± 0.116 (16.4) 0.003 ± 0.0004 (16.4)
Cd <0.036 <0.0002 <0.010 <0.0001 0.201 ± 0.057 (28.6) 0.0008 ± 0.0002 (28.6)
Cr <0.464 <0.002 0.169 ± 0.158 (93.1) 0.002 ± 0.002 (93.1) 13.4 ± 14.8 (111) 0.050 ± 0.056 (111)
Cu 3.63 ± 1.15 (31.8) 0.018 ± 0.006 (31.8) 1.67 ± 2.04 (123) 0.019 ± 0.024 (123) 22.4 ± 2.2 (9.89) 0.084 ± 0.008 (9.89)
Fe <17.4 <0.087 <20.7 <0.238 <28.5 <0.107
Mn <0.317 <0.001 4.75 ± 1.89 (40) 0.055 ± 0.022 (40) 43.7 ± 6.0 (13.8) 0.164 ± 0.023 (13.8)
Ni <0.285 <0.001 0.079 ± 0.078 (99.3) 0.001 ± 0.001 (99.3) 3.59 ± 2.02 (56.4) 0.013 ± 0.008 (56.4)
Pb <0.359 <0.004 0.383 ± 0.205 (53.5) 0.004 ± 0.002 (53.5) 3.81 ± 0.02 (0.578) 0.014 ± 0.0001 (0.578)
Zn 96.0 ± 47.7 (49.7) 0.480 ± 0.238 (49.7) 537 ± 82 (15.3) 6.18 ± 0.95 (15.3) 2190 ± 215 (9.85) 8.19 ± 0.81 (9.85)
< indicates a value less than the instrumental detection limit, n number of replicates
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the third group. For the UBM, the first group included Cd, Cr,
Mn and Zn; the second group Cu (+29%) and Pb (+17%); and
the third As (−6%), Fe (−35%) and Ni (−13%).
The difference in solubility of PTE between the single
and the sequential procedures is due to interaction between
a number of factors. One of most important is pH. The ad-
dition of 1.5 mL residual AMF to the step 2 reagent in-
creases the pH from the typical values of 1.5 (SBET) or
1.2 (UBMG) and this may be responsible for the decreased
recoveries of Cd for the AMF→SBET sequential extraction
relative to the SBET, and of Fe and Ni for the AMF→
UBMG sequential extraction, relative to the stomach phase
of the UBM. The composition of the extractants is also in-
fluential, especially the exchangeable ion and complexing
ligand contents. For the AMF→SBETsequential extraction,
enhanced release of As and Cr may have been due to the
presence of NaH2PO4 in the step 1 reagent. Ion exchange
reactions between PO4
3− in solution and oxyanions (AsO3
3
−, AsO4
3− and CrO4
2−) at the edges of soil particles can
increase analyte solubility [42]. This was not observed for
the AMF→UBMG sequence because the UBMG reagent
already contained phosphate. The greater amounts of Cu
and Pb extracted when either AMF→SBET or AMF→
UBMG was applied may be due to the presence of larger
numbers and amounts of complexing organic acids in the
sequential extraction reagents than in the SBET or UBM
(stomach phase) alone. Both these elements have a high
affinity for organic acid ligands [43].
Quality control
The results obtained show that the spike recoveries of PTE
(see Tables 4 and 5) in all extraction procedures conducted in
this work were between 85 and 114% except for Fe, where it
was 72.6 and 70.7% for SBET2 and UBMG, respectively,
when these were conducted sequentially after the extraction
by the AMF. This may be due to the formation of insoluble
phosphates of Fe [42]. For the precision expressed as relative
standard deviation (% RSD), approximately 87% of the RSD
values were <10, and 13% of the values were between 10 and
<15% (see Tables 4 and 5).
Conclusion
In this work, a novel artificial AMF was designed for use as
the first step of a sequential extraction, in combination with
either the SBET or the UBMG oral bioaccessibility test, to
better simulate physiological conditions experienced by PM
transported into the gastrointestinal tract by mucociliary clear-
ance and thus provide a more accurate estimation of the hu-
man bioaccessibility of PM-bound PTE following inhalation.
Methods were developed successfully using simulated PM
samples composed of a soil reference material supported on
TX40 filters used in FDMS systems for continuous measure-
ment of airborne particulate matter. Analysis of blank TX40
FDMS filters revealed that bioaccessible concentration of all
Table 5 Sequential extraction step 2: bioaccessible concentrations of
potentially toxic elements in simulated PM10 samples (soil on TX40
FDMS filters) and in soil alone extracted using either the simplified
bioaccessibility extraction test (SBET) or the stomach phase of the unified
bioaccessibility method (gastric fluid only) (UBMG), following extrac-
tion with artificial mucus fluid in step 1 (see Table 4)
Sample %Spike
recovery
%RPD
Soil Soil on TX40 filters
SBET UBMG SBET UBMG SBET UBMG SBET UBMG
Mean ± SD
(mg kg−1)
(n = 3)
%RSD Mean ± SD
(mg kg−1)
(n = 3)
%RSD Mean ± SD
(mg kg−1)
(n = 3)
%RSD Mean ± SD
(mg kg−1)
(n = 3)
%RSD
As 3.09 ± 0.09 2.85 3.54 ± 0.08 2.22 2.98 ± 0.07 2.37 3.38 ± 0.07 2.18 94.4 95.6 3.56 4.59
Cd 0.149 ± 0.005 3.42 0.224 ± 0.013 5.71 0.145 ± 0.003 2.33 0.219 ± 0.021 9.40 90.9 97.2 2.10 2.17
Cr 30.8 ± 0.8 2.50 39.3 ± 1.4 3.43 30.5 ± 0.2 0.784 33.9 ± 2.1 6.07 88.0 97.3 1.11 14.6
Cu 6.02 ± 0.09 1.41 7.47 ± 0.45 6.05 6.36 ± 0.08 1.28 7.11 ± 0.80 11.3 90.5 96.8 5.48 4.91
Fe 1040 ± 13 1.25 903 ± 55 6.13 1030 ± 14 1.39 842 ± 26 3.11 72.6 70.7 0.321 6.94
Mn 1840 ± 29 1.58 2710 ± 113 4.16 1800 ± 26 1.45 2600 ± 144 5.57 89.2 108 2.35 4.40
Ni 7.97 ± 0.07 0.933 11.4 ± 0.5 3.99 7.79 ± 0.15 1.94 10.4 ± 0.3 3.11 90.1 94.1 2.34 9.60
Pb 18.4 ± 0.3 1.59 23.1 ± 1.1 4.71 17.8 ± 0.3 1.79 21.6 ± 1.1 4.91 85.0 101 3.15 6.77
Zn 28.9 ± 0.7 2.49 40.3 ± 2.5 6.26 21.9 ± 2.9 13.3 30.9 ± 1.8 5.73 86.2 107 27.5 26.5
SD standard deviation, n number of replicates, RSD relative standard deviation, RPD relative percent difference = {|a1 − a2|/((a1 + a2)/2)} × 100 where
a1 is values in soil alone and a2 is values in soil loaded on TX40 filter
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PTE tested was low, except for Zn, where a significant blank
concentration was found. Different amounts of analytes (ex-
cept Mn and Zn) were recovered using the sequential
extraction procedures (AMF→SBET and AMF→UBMG)
than when the respective SBET or UBM (stomach phase)
were applied alone. Both sequential extraction procedures
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Fig. 1 Comparison between the bioaccessible concentrations of
potentially toxic elements obtained by sequential extraction and by use
of an oral bioaccessibility test alone for simulated PM10 samples (soil on
TX40 FDMS filters). Results are expressed as the relative recovery of the
sequential procedures relative to their corresponding single-step oral
bioaccessibility test, where AMF→SBET = sequential extraction with
artificial mucus fluid followed by the simplified bioaccessibility
extraction test; AMF→UBMG = sequential extraction with artificial
mucus fluid followed by the stomach phase of the unified
bioaccessibility method (gastric fluid only); SBET = simplified
bioaccessibility extraction test alone; UBM = stomach phase of the
unified bioaccessibility method alone. Error bar represents 1 standard
deviation, n = 3. Data for the SBET and UBM procedures alone from
reference [34]
Table 6 Statistical comparison
between the bioaccessible
concentrations of potentially toxic
elements obtained by sequential
extraction and by use of an oral
bioaccessibility test alone for
simulated PM10 samples (soil on
TX40 FDMS filters)
PTE SBET vs. AMF→SBET (ν = 4) UBM (stomach phase) vs. AMF→UBM (ν = 4)
t calculated t calculated
As 37.44 4.19
Cd 9.78 0.16
Cr 11.08 0.91
Cu 9.60 4.30
Fe 2.48 14.92
Mn 1.44 1.96
Ni 0.48 6.88
Pb 16.95 3.20
Zn 2.52 1.93
ν degree of freedom, significance level (α) = 0.05, t critical for all cases = 2.78, AMF→SBET sequential extraction
with artificial mucus fluid followed by the simplified bioaccessibility extraction test, AMF→UBMG sequential
extractionwith artificial mucus fluid followed by the stomach phase of the unified bioaccessibility method (gastric
fluid only), SBET simplified bioaccessibility extraction test alone, UBM stomach phase of the unified bioacces-
sibility method alone. Italics indicates values that failed the t test
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isolated greater amounts of Cu and Pb than the equivalent oral
bioaccessibility tests. The AMF→SBET procedure also re-
covered higher quantities of Cr and, especially As (more than
twice the amount released by the SBET procedure alone). The
study demonstrated that, to assess the bioaccessibility of PTE
associated with inhaled PM, a sequential extraction test in-
volving AMF followed by artificial gastric fluid (either the
SBET or the UBM) should be adopted, otherwise the bioac-
cessible concentration of trace elements with potentially seri-
ous impact on human health may be estimated incorrectly.
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